BACKGROUND:
Hyponatremia is common in hospitalized patients with heart failure (HF) and predicts a poor prognosis after discharge. In general, hyponatremia can be divided into two types: dilutional or depletional.
OBJECTIVE:
Assess the impact of hyponatremia type on short-term outcomes.
DESIGN:
Retrospective cohort
SETTINGS:
Single center in China
PATIENTS AND METHODS:
We sorted patients by hyponatremia into two types: dilutional hyponatremia (DiH, with hematocrit <35%) and depletional hyponatremia (DeH, with hematocrit ≥35%). The Kaplan-Meier method and Cox regression analysis were used to identify the impact of hyponatremia types on the risk for 90-day readmission and death.
MAIN OUTCOME MEASURES:
90-day readmission and death combined.
SAMPLE SIZE:
1770 patients.
RESULTS:
Hyponatremia was present in 324/1770 patients with 182 cases classified as DiH versus 142 as DeH. Kaplan-Meier analyses showed a higher incidence of poor short-term outcomes in hyponatremia compared with normonatremia (log-rank
P
<.001), and the risk was higher in DiH than DeH although the difference was not statistically significant (log-rank
P
=.656). Multivariate Cox regression analyses showed that only DiH was independently associated with short-term outcomes (HR=1.34, 95%CI: 1.02-1.77,
P
=.038), but not DeH (HR=1.32, 95%CI: 0.97-1.80,
P
=.081). Analysis of the secondary endpoints showed that DiH increased the risk of readmission but not death (HR=1.36,
P
=.035 for readmission; HR=1.13,
P
=.831 for all-cause death).
CONCLUSIONS:
Low hematocrit, rather than high hematocrit, with hyponatremia was associated with a risk of 90-day readmission in patients with HF.
LIMITATIONS:
Single center, nonrandomized.
CONFLICT OF INTEREST:
None.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.